
Cartalax is a short-chain peptide extensively researched for its role in cartilage, joint, and connective tissue-related studies. It is commonly used in musculoskeletal research, regenerative science, and age-associated cellular research involving cartilage structures.
私たちのカルタラックス20mgis produced withhigh purity and consistent peptide sequencing, ensuring reproducibility across different research projects. Supplied in lyophilized powder form, the product offers excellent stability, making it ideal for long-term storage and extended research cycles.
Cartalax is frequently selected by laboratories and distributors focusing on joint research, orthopedic science, and tissue regeneration-related peptide programs.
Cartalax 20mg (Bioregulator) Cartalax is a bioregulatory peptide renowned for its systemic effects, particularly on fibroblasts which play a crucial role in tissue repair and senescence across various body systems including the skin, connective tissues, and kidneys. Recognized primarily for its anti-aging properties, Cartalax enhances cell proliferation, improves cell health, and reduces cellular senescence, effectively rejuvenating older cells and promoting longer-lasting tissue health. Product Usage: Cartalax is designated solely for research purposes. It is intended for in vitro testing and laboratory experiments only. All the information provided on this website is for educational purposes. Introducing this compound into humans or animals is strictly prohibited by law. This product must be handled by licensed, qualified professionals and should not be misused as a drug, food, or cosmetic. Introduction Cartalax is a short peptide known for its significant bioregulatory effects. It targets fibroblasts, which are integral in maintaining the structural integrity of various tissues including cartilage, skin, and blood vessels. The peptide is involved in crucial cellular functions such as cell proliferation and apoptosis, making it a key player in anti-aging and tissue regeneration research. Comprehensive Overview and Research Applications Effects on Skin and Connective Tissues Cartalax has been shown to enhance the proliferation of skin cells and the regeneration of tissues, especially in aging models. It modifies the expression of critical cytokines and signaling molecules, reducing the processes associated with aging and promoting a more youthful cellular environment. Cartalax and Kidney Health Research indicates that Cartalax can stimulate cell renewal in kidney tissues, particularly beneficial in older animals. This regenerative capability is due to its effects on increasing proliferation markers like Ki-67 while decreasing pro-apoptotic signals such as p53.Peptidegurusは、アメリカ製の研究ペプチドの大手サプライヤーであり、競争力のある価格で最高品質の製品を提供しています。卓越性と顧客サービスに重点を置いて、彼らはグローバルな配送で安全で便利な注文プロセスを保証します。
©Copyright Peptide Gurus2024。AllRights Reserved。プライバシーポリシー 本サイトのすべての製品は研究・開発用途のみを対象としています。製品は人間の消費物ではありません。このウェブサイトに記載されている声明は、米国食品医薬品局(FDA)やカナダ保健省によって評価されていません。本社の声明および製品は、いかなる病気の診断、治療、治癒、予防を目的としたものではありません。PeptideGurusは化学薬品の供給業者です。PeptideGurusは、連邦食品医薬品化粧品法503A条に基づく調剤薬局や化学調剤施設ではありません。Peptide Sciencesは連邦食品医薬品化粧品法503B条に基づくアウトソーシング施設ではありません。
接触